The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Antiinflammatory effects of dexamethasone are partly dependent on induction of dual specificity phosphatase 1
Open accessAbstract
Glucocorticoids (GCs), which are used in the treatment of immune-mediated inflammatory diseases, inhibit the expression of many inflammatory mediators. They can also induce the expression of dual specificity phosphatase 1 (DUSP1; otherwise known as mitogen-activated protein kinase [MAPK] phosphatase 1), which dephosphorylates and inactivates MAPKs. We investigated the role of DUSP1 in the antiinflammatory action of the GC dexamethasone (Dex). Dex-mediated inhibition of c-Jun N-terminal kinase and p38 MAPK was abrogated in DUSP1-/- mouse macrophages. Dex-mediated suppression of several proinflammatory genes (including tumor necrosis factor, cyclooxygenase 2, and interleukin 1alpha and 1beta) was impaired in DUSP1-/- mouse macrophages, whereas other proinflammatory genes were inhibited by Dex in a DUSP1-independent manner. In vivo antiinflammatory effects of Dex on zymosan-induced inflammation were impaired in DUSP1-/- mice. Therefore, the expression of DUSP1 is required for the inhibition of proinflammatory signaling pathways by Dex in mouse macrophages. Furthermore, DUSP1 contributes to the antiinflammatory effects of Dex in vitro and in vivo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“GR-mediated transactivation typically induces the expression of potent signaling inhibitors (e.g., IκBα, MPK-1, IL-10, Annexin A1, GILZ, and SOCS proteins), which strongly interfere with salient immune signaling pathways such as those triggered by the Toll-like receptors (TLR) (82–85).”
From The HPA – Immune Axis and the Immunomodulatory Actions of Glucocorticoids in the Brain (2014) · cites this paper as [82]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA binding of the glucocorticoid receptor is not essential for survival
Reichardt, H. M., Kaestner, K. H., Tuckermann, J., Kretz, O., Wessely, O., Bock, R., Gass, P., Schmid, W., Herrlich, P., Angel, P., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81183-6 · Cited by 1,068
Self-citationDual specificity phosphatases: a gene family for control of MAP kinase function
Camps, M., NICHOLS, A., & Arkinstall, S. (2000) · The FASEB Journal · doi:10.1096/fasebj.14.1.6 · Cited by 823
Possible new role for NF-κB in the resolution of inflammation
Lawrence, T., Gilroy, D. W., Colville‐Nash, P., & Willoughby, D. A. (2001) · Nature Medicine · doi:10.1038/nm1201-1291 · Cited by 753
Molecular determinants of crosstalk between nuclear receptors and toll-like receptors
Ogawa, S., Lozach, J., Benner, C., Pascual, G., Tangirala, R. K., Westin, S., Hoffmann, A., Subramaniam, S., David, M., Rosenfeld, M. G., et al. (2005) · Cell · doi:10.1016/j.cell.2005.06.029 · Cited by 647
Chi, H., Barry, S. P., Flach, R. J. R., Wu, J. J., Jones, E. A., Bennett, A. M., & Flavell, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0510965103 · Cited by 568
Molecular mechanisms of glucocorticoid action: what is important?
Newton, R. C. (2000) · Thorax · doi:10.1136/thorax.55.7.603 · Cited by 507
Swantek, J. L., Cobb, M. H., & Geppert, T. D. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.11.6274 · Cited by 491
Repression of inflammatory responses in the absence of DNA binding by the glucocorticoid receptor
Reichardt, H. M., Tuckermann, J. P., Göttlicher, M., Vujic, M., Weih, F., Angel, P., Herrlich, P., & Schütz, G. (2001) · The EMBO Journal · doi:10.1093/emboj/20.24.7168 · Cited by 429
MAP kinase phosphatase 1 controls innate immune responses and suppresses endotoxic shock
Zhao, Q., Wang, X., Nelin, L. D., Yao, Y., Matta, R., Manson, M. E., Baliga, R. S., Meng, X., Smith, C. V., Bauer, J. A., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051794 · Cited by 370
Essential Role of MAPK Phosphatase-1 in the Negative Control of Innate Immune Responses
Salojin, K. V., Owusu, I. B., Millerchip, K. A., Potter, M. D., Platt, K. A., & Oravecz, T. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.176.3.1899 · Cited by 333
Flagged first, then by citations
Research works printed but not linked: 3
- 2005, Curr. Opin. Investig. Drugs., 6, 503
- 1996, Oncogene., 13, 925
- 2002, FASEB J., 16, 1832
Cited by
Sorted by citations
Items 201–300 of 430
Jin, Y., Hu, D., Peterson, E. L., Eng, C. S., Levin, A. M., Wells, K. E., Beckman, K. B., Kumar, R., Seibold, M. A., Karungi, G., et al. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.06.007 · Cited by 35
Regulatory network of inflammation downstream of proteinase-activated receptors
Saban, R., D’Andrea, M. R., Andrade‐Gordon, P., Derian, C. K., Dozmorov, I. M., Ihnat, M. A., Hurst, R. E., Simpson, C., & Saban, M. R. (2007) · BMC Physiology · doi:10.1186/1472-6793-7-3 · Cited by 36
Webster, J. M., Fenton, C. G., LANGEN, R. C. J., & Hardy, R. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20225768 · Cited by 36
Lim, J., Shin, N., Seo, Y., Nam, H., Ko, J., Jung, T.-Y., Lee, S., Kim, H., Cho, Y.-K., Kim, J.-C., et al. (2020) · Cells · doi:10.3390/cells9030678 · Cited by 34
Drug targets, mechanisms of drug action, and therapeutics against SARS-CoV-2
Jena, N. R. (2021) · Chemical Physics Impact · doi:10.1016/j.chphi.2021.100011 · Cited by 34
Hoffmann, M., Singh, P., Wolk, R. A., Narkiewicz, K., & Somers, V. K. (2013) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2013.09.033 · Cited by 34
Chiloeches, A., Sánchez‐Pacheco, A., Gil-Araujo, B., Aranda, A., & Lasa, M. (2008) · Molecular Endocrinology · doi:10.1210/me.2008-0107 · Cited by 34
Importance of glucocorticoid receptors in upper and lower airways
Pujols, L. (2009) · Frontiers in bioscience · doi:10.2741/3646 · Cited by 33
Keenan, C. R., Radojicic, D., Li, M., Radwan, A. M., & Stewart, A. G. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.01.006 · Cited by 36
Protective Roles for RGS2 in a Mouse Model of House Dust Mite-Induced Airway Inflammation
George, T., Bell, M., Chakraborty, M., Siderovski, D. P., Giembycz, M. A., & Newton, R. C. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170269 · Cited by 31
Bladh, L.-G., Johansson-Haque, K., Rafter, I., Nilsson, S. V., & Okret, S. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.11.013 · Cited by 32
Lasa, M., Gil-Araujo, B., Palafox, M., & Aranda, A. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0298 · Cited by 32
Shah, S., Mostafa, M., McWhae, A., Traves, S. L., & Newton, R. C. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.697599 · Cited by 31
Altonsy, M. O., Mostafa, M., Gerber, A. N., & Newton, R. C. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00426.2016 · Cited by 31
Emerging Regulatory Roles of Dual-Specificity Phosphatases in Inflammatory Airway Disease
Manley, G. C. A., Parker, L. C., & Zhang, Y. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030678 · Cited by 32
Fürst, R., Stefan Zahler, A., & Vollmar, A. M. (2008) · Endocrinology · doi:10.1210/en.2007-1524 · Cited by 31
Chen, W., Yen, C., Huang, W., Hsu, Y., Ou, G., & Hsu, M. (2014) · British Journal of Pharmacology · doi:10.1111/bph.13040 · Cited by 30
Chiarella, P., Vulcano, M., Bruzzo, J., Vermeulen, M. E., Vanzulli, S. I., Maglioco, A., Camerano, G., Palacios, V., Fernández, G. C., Fernández‐Brando, R. J., et al. (2007) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-007-0410-4 · Cited by 30
Wilson, C., Scullin, P., Worthington, J., Seaton, A., Maxwell, P., O’Rourke, D. M., Johnston, P. G., McKeown, S. R., Wilson, R., O’Sullivan, J. M., et al. (2008) · British Journal of Cancer · doi:10.1038/sj.bjc.6604804 · Cited by 30
Ramesh, G., Meisner, O. C., & Philipp, M. T. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0461-y · Cited by 30
Hidasi, A. O., Groh, K. J., Suter, M. J. ‐., & Schirmer, K. (2016) · Ecotoxicology and Environmental Safety · doi:10.1016/j.ecoenv.2016.11.024 · Cited by 29
Eiers, A.-K., Vettorazzi, S., & Tuckermann, J. P. (2024) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-225371 · Cited by 31
Glucocorticoid Receptor in Human Respiratory Epithelial Cells
Pujols, L., Mullol, J., & Picado, C. (2009) · NeuroImmunoModulation · doi:10.1159/000216187 · Cited by 29
Larangé, A., Antonios, D., Pallardy, M. J., & Kerdine‐Römer, S. (2011) · Journal of Leukocyte Biology · doi:10.1189/jlb.1110615 · Cited by 29
Malfait, A., Tortorella, M. D., Thompson, J. F., Hills, R. L., Dk, M., JAFFEE, B. D., Chinn, K., Ghoreishi-Haack, N. S., Markosyan, S., & Arner, E. C. (2008) · Osteoarthritis and Cartilage · doi:10.1016/j.joca.2008.10.005 · Cited by 29
Resistance of LPS-activated bone marrow derived macrophages to apoptosis mediated by dexamethasone
Ohana, Y. H., Deshet‐Unger, N., Souroujon, M. C., Mittelman, M., & Neumann, D. (2014) · Scientific Reports · doi:10.1038/srep04323 · Cited by 29
Hu, Y., Carman, J., Holloway, D. A., Kansal, S., Li, F., Goldstine, C. B., Lee, D., Somerville, J. E., Latek, R. R., Townsend, R. C., et al. (2018) · Arthritis & Rheumatology · doi:10.1002/art.40476 · Cited by 28
Dexamethasone attenuates interferon-related cytokine hyperresponsiveness in COVID-19 patients
Engel, J. J., van der Made, C. I., Keur, N., Setiabudiawan, T. P., Röring, R. J., Damoraki, G., Dijkstra, H., Lemmers, H., Ioannou, S., Poulakou, G., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1233318 · Cited by 33
Molecular determinants of glucocorticoid actions in inflammatory joint diseases
Baschant, U., Culemann, S., & Tuckermann, J. P. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.06.009 · Cited by 29
Two Faces of Inflammation: An Immunopharmacological View
Moilanen, E. (2013) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12180 · Cited by 28
McGuire, V. A., Rosner, D., Ananieva, O., Ross, E. A., Elcombe, S. E., Naqvi, S., van den Bosch, M. W. M., Monk, C. E., Diez, T. R.-Z., Clark, A. R., et al. (2016) · Molecular and Cellular Biology · doi:10.1128/mcb.00454-16 · Cited by 28
McCrory, E. H., Akimov, V., Cohen, P., & Blagoev, B. (2022) · Biochemical Journal · doi:10.1042/bcj20220510 · Cited by 25
Genome-Wide Posttranscriptional Dysregulation by MicroRNAs in Human Asthma as Revealed by Frac-seq
Martínez-Nuñez, R. T., Rupani, H., Platé, M., Niranjan, M., Chambers, R. C., Howarth, P. H., & Sánchez-Elsner, T. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701798 · Cited by 28
Pemmari, A., Paukkeri, E., Hämäläinen, M., Leppänen, T., Korhonen, R., & Moilanen, E. (2018) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.13163 · Cited by 28
Kim, M. W., Moon, H., Yang, S. J., & Joe, S. G. (2016) · Korean Journal of Ophthalmology · doi:10.3341/kjo.2016.30.1.25 · Cited by 27
Rashamol, V. P., Sejian, V., Bagath, M., Krishnan, G., Beena, V., & Bhatta, R. (2019) · International Journal of Biometeorology · doi:10.1007/s00484-019-01713-1 · Cited by 26
Targeting Macrophage Dysregulation for Viral Infections: Novel Targets for Immunomodulators
Reece, M. D., Taylor, R. R., Song, C., & Gavegnano, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.768695 · Cited by 26
Peng, X., Li, Y., Zhao, W., Yang, S., Huang, J., Chen, Y., Wang, Y., Gong, Z., Chen, X., Yu, C., et al. (2023) · International Immunopharmacology · doi:10.1016/j.intimp.2023.109719 · Cited by 26
Robitaille, A. C., Caron, E., Zucchini, N., Mukawera, E., Adam, D., Mariani, M. K., Gélinas, A., Fortin, A., Brochiero, E., & Grandvaux, N. (2017) · Scientific Reports · doi:10.1038/s41598-017-17689-0 · Cited by 26
Lung Targeted Lipopolymeric Microspheres of Dexamethasone for the Treatment of ARDS
Kotta, S., Aldawsari, H. M., Badr-Eldin, S. M., Binmahfouz, L. S., Bakhaidar, R. B., Sreeharsha, N., Nair, A. B., & Ramnarayanan, C. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13091347 · Cited by 25
Exercise Training Upregulates Macrophage MKP-1 and Affects Immune Responses in Mice
Chen, M., Chen, H., & Jen, C. J. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e2158d · Cited by 25
Functional metabotropic glutamate receptors 1 and 5 are expressed in murine podocytes
Gu, L., Liang, X., Wang, L., Yan, Y., Ni, Z., Dai, H., Gao, J., Mou, S., Wang, Q., Chen, X., et al. (2011) · Kidney International · doi:10.1038/ki.2011.406 · Cited by 25
Korhonen, R., Huotari, N., Hömmö, T., Leppänen, T., & Moilanen, E. (2012) · Molecular Immunology · doi:10.1016/j.molimm.2012.03.019 · Cited by 24
Giembycz, M. A., & Newton, R. C. (2013) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2013.09.007 · Cited by 24
Bao, A., Li, F., Zhang, M., Chen, Y., Zhang, P., & Zhou, X. (2014) · Respiratory Research · doi:10.1186/s12931-014-0126-x · Cited by 24
Self-powered therapeutic release from conducting polymer/graphene oxide films on magnesium
Catt, K. A., Li, H., Hoang, V., Beard, R., & Cui, X. T. (2017) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2017.02.021 · Cited by 24
Zhang, Q., Fujino, M., Xu, J., & Li, X. (2015) · Mediators of Inflammation · doi:10.1155/2015/421927 · Cited by 24
Pfänder, P., Fidan, M., Burret, U., Lipinski, L., & Vettorazzi, S. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01554 · Cited by 24
EGR-1 and DUSP-1 are important negative regulators of pro-allergic responses in airway epithelium
Golebski, K., van Egmond, D., de Groot, E. J., Roschmann, K. I. L., Fokkens, W. J., & van Drunen, C. M. (2015) · Molecular Immunology · doi:10.1016/j.molimm.2014.12.011 · Cited by 22
MKP-1 Knockout Does not Prevent Glucocorticoid-Induced Bone Disease in Mice
Conradie, M., Cato, A. C. B., Ferris, W. F., de Wet, H., Horsch, K., & Hough, S. F. (2011) · Calcified Tissue International · doi:10.1007/s00223-011-9509-x · Cited by 23
Ayush, O., Lee, C., Kim, H.-K., Im, S., Cho, B., & Lee, H.-K. (2012) · Journal of Investigative Dermatology · doi:10.1038/jid.2012.373 · Cited by 23
Identification of NURR1 as a Mediator of MIF Signaling During Chronic Arthritis
Ralph, J. A., Ahmed, A. U., Santos, L. L., Clark, A. R., McMorrow, J. P., Murphy, E. P., & Morand, E. F. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.091204 · Cited by 22
Park, H. S., Nelson, D. E., Taylor, Z. E., Hayes, J. B., Cunningham, K. D., Arivett, B. A., Ghosh, R. K., Wolf, L. C., Taylor, K. M., Farone, M. B., et al. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.12.004 · Cited by 24
Karaman, T., Karaman, S., Doğru, S., Tapar, H., Sahin, A., & Süren, M. (2017) · Türk anesteziyoloji ve reanimasyon derneği dergisi · doi:10.5152/tjar.2017.98624 · Cited by 23
Lai, T., Yang, C., Yang, C., Ho, T., & Hsieh, Y. (2018) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2018.03.009 · Cited by 22
A Jack of All Trades: Impact of Glucocorticoids on Cellular Cross-Talk in Osteoimmunology
Ahmad, M., Hachemi, Y., Paxian, K., Mengele, F., Koenen, M., & Tuckermann, J. P. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02460 · Cited by 22
Glucocorticoid-Induced Osteoporosis ? A Disorder of Mesenchymal Stromal Cells?
Hardy, R., & Cooper, M. S. (2011) · Frontiers in Endocrinology · doi:10.3389/fendo.2011.00024 · Cited by 22
Adcock, I. M., & Caramori, G. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-374001-4.00031-6 · Cited by 25
IRF2BP2 modulates the crosstalk between glucocorticoid and TNF signaling
Manjur, A. B. M. K., Lempiäinen, J. K., Malinen, M., Palvimo, J. J., & Niskanen, E. A. (2019) · The Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2019.105382 · Cited by 21
Protein kinase networks that limit TLR signalling
Clark, K. (2014) · Biochemical Society Transactions · doi:10.1042/bst20130124 · Cited by 21
Spinelli, S. L., Xi, X., McMillan, D. H., Woeller, C. F., Richardson, M. E., Cavet, M. E., Zhang, J.-Z., Feldon, S. E., & Phipps, R. P. (2014) · Experimental Eye Research · doi:10.1016/j.exer.2014.07.013 · Cited by 20
Keränen, T., Moilanen, E., & Korhonen, R. (2017) · Inflammation Research · doi:10.1007/s00011-017-1028-4 · Cited by 20
Qi, R., & Wang, X. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.106091 · Cited by 20
RetractedCoz, G.-M. L., Anton, F., & Hanesch, U. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091393 · Cited by 21
Glucocorticoid therapy for acute respiratory distress syndrome: Current concepts
Zhao, Y., Yao, Z., Xu, S., Yao, L., & Yu, Z. (2024) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2024.02.002 · Cited by 20
Emerging role of the Jun N‐terminal kinase interactome in human health
Guo, X., An, S., Yang, Y., Liu, Y., Hao, Q., Tang, T., & Xu, T. (2018) · Cell Biology International · doi:10.1002/cbin.10948 · Cited by 19
Xi, B., Liu, H., Sun, J., Zhang, X., Li, N., & Chen, M. (2020) · Aesthetic Plastic Surgery · doi:10.1007/s00266-020-01743-w · Cited by 19
Razavi, M., Wang, J., & Thakor, A. S. (2021) · Science Advances · doi:10.1126/sciadv.abf9221 · Cited by 19
P38 inhibition in COPD; cautious optimism
Singh, D. (2013) · Thorax · doi:10.1136/thoraxjnl-2013-203498 · Cited by 19
Ferreira, T. P. T., Lima, J. G. M. E., Farias‐Filho, F. A., de Sá, Y. A. P. J., de Arantes, A. C. S., Guimarães, F. V., Carvalho, V. F., Hogaboam, C. M., Wallace, J. L., Martins, M. A., et al. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00388 · Cited by 18
Lee, C.-H., Kim, H.-K., Kim, J., Ayush, O., Im, S., Oh, D.-K., & Lee, H.-K. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201599 · Cited by 18
Glucocorticoid Resistance in Inflammatory Diseases
Chrousos, G., & Franchimont, D. (2004) · CRC Press eBooks · doi:10.1201/9780203021941-39 · Cited by 21
Targeted Redesign of Suramin Analogs for Novel Antimicrobial Lead Development
Dey, D., Ramakumar, S., & Conn, G. L. (2021) · Journal of Chemical Information and Modeling · doi:10.1021/acs.jcim.1c00578 · Cited by 17
Regulation of tristetraprolin expression by mitogen‐activated protein kinase phosphatase‐1
Huotari, N., Hömmö, T., Taimi, V., Nieminen, R. M., Moilanen, E., & Korhonen, R. (2012) · Apmis · doi:10.1111/j.1600-0463.2012.02927.x · Cited by 17
Prostaglandins mediate zymosan-induced sickness behavior in mice
de Lima, J. B. M., Veloso, C. C., Vilela, F. C., & Giusti‐Paiva, A. (2016) · The Journal of Physiological Sciences · doi:10.1007/s12576-016-0494-8 · Cited by 17
Pinart, M., Hussain, F., Shirali, S., Li, F., Zhu, J., Clark, A. R., Ammit, A. J., & Chung, K. F. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.10.003 · Cited by 16
Host Directed Therapies for Tuberculous Meningitis
Davis, A., Donovan, J., Bremer, M., van Toorn, R., Schoeman, J. F., Dadabhoy, A., Lai, R., Cresswell, F. V., Boulware, D. R., Wilkinson, R. J., et al. (2021) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16474.2 · Cited by 16
Park, H., Vick, E. J., Gao, Y., He, C., Almosnid, N. M., Farone, M. B., & Farone, A. L. (2016) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2016.05.042 · Cited by 16
Jeong, H., Yoon, H., Lee, Y., Kim, J. T., Yang, M., Kim, G., Jung, B., Park, S. H., & Lee, C. (2022) · Immune Network · doi:10.4110/in.2022.22.e33 · Cited by 15
Cellular Immunobiology and Molecular Mechanisms in Alloimmunity—Pathways of Immunosuppression
Schrezenmeier, E. V., Dörner, T., Halleck, F., & Budde, K. (2023) · Transplantation · doi:10.1097/tp.0000000000004646 · Cited by 16
Al-Zamil, W. M. (2014) · Saudi Journal of Ophthalmology · doi:10.1016/j.sjopt.2014.10.005 · Cited by 15
Pinheiro, R. P., Moraes, M. A., Santos, B. C. S., Fabri, R. L., Del-Vechio-Vieira, G., Yamamoto, C. H., Araújo, A. L. S. M., Araújo, A. L. A., & de Sousa, O. V. (2017) · Inflammopharmacology · doi:10.1007/s10787-017-0415-3 · Cited by 14
Host Directed Therapies for Tuberculous Meningitis
Davis, A., Donovan, J., Bremer, M., van Toorn, R., Schoeman, J. F., Dadabhoy, A., Lai, R., Cresswell, F. V., Boulware, D. R., Wilkinson, R. J., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16474.1 · Cited by 14
Mitogen-activated protein kinase phosphatase-1: function and regulation in bone and related tissues
Broome, D. T., & Datta, N. S. (2016) · Connective Tissue Research · doi:10.3109/03008207.2015.1125480 · Cited by 14
Molina, M. L., Guerrero, J., Cidlowski, J. A., Gatica, H., & Annelise Goecke, S. (2017) · Journal of Inflammation · doi:10.1186/s12950-017-0169-0 · Cited by 15
Catley, M. C. (2007) · The Scientific World JOURNAL · doi:10.1100/tsw.2007.97 · Cited by 14
Rousseau, S. (2011) · AfCS-Nature Molecule Pages · doi:10.1038/mp.a001717.01 · Cited by 13
Milara, J., Morell, A., Roger, I., Montero, P., & Cortijo, J. (2023) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2023.2255124 · Cited by 14
Hu, C., Xun, Q., Li, X., Hu, X., Qin, L., He, R., & Feng, J. (2018) · Chinese Medical Journal · doi:10.4103/0366-6999.246061 · Cited by 13
Kusakabe, T., Sawaji, Y., Endo, K., Suzuki, H., Konishi, T., Maekawa, A., Murata, K., & Yamamoto, K. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms23010371 · Cited by 13
Mansouri, A., Kowsar, R., Zakariazadeh, M., Hakimi, H., & Miyamoto, A. (2022) · Scientific Reports · doi:10.1038/s41598-022-04778-y · Cited by 13
Regulation of Inflammatory Cytokine Production by MKP‐5 in Macrophages
Hömmö, T., Pesu, M., Moilanen, E., & Korhonen, R. (2015) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12380 · Cited by 13
Oxidants Induce a Corticosteroid-Insensitive Phosphorylation of Histone 3 at Serine 10 in Monocytes
Marwick, J. A., Tudor, C., Khorasani, N. M., Michaeloudes, C., Bhavsar, P. K., & Chung, K. F. (2015) · PLoS ONE · doi:10.1371/journal.pone.0124961 · Cited by 13
Corticosteroid receptor expression and in vivo glucocorticoid sensitivity in multiple sclerosis
Bechmann, L., Busse, K., Stoppe, M., Cotte, S., Ettrich, B., & Bergh, F. T. (2014) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2014.07.004 · Cited by 13
Donet, E., Bosch, P., Sanchís, A., Bayo, P., Ramı́rez, Á., Cascallana, J. L., Bravo, A., & Paloma, P. (2008) · Molecular Endocrinology · doi:10.1210/me.2007-0284 · Cited by 13
Poupouzas, G. I., Lotsios, N. S., Vrettou, C. S., Issaris, V., Keskinidou, C., Papavassiliou, K. A., Halioti, A., Botoula, E., Tzanela, M., Papavassiliou, A. G., et al. (2025) · Critical Care · doi:10.1186/s13054-025-05628-9 · Cited by 12
Inbaraj, S., Sejian, V., & Ramasamy, S. (2019) · Biological Rhythm Research · doi:10.1080/09291016.2019.1695084 · Cited by 14
Shafeek, F., El‐Kashef, D. H., Abu‐Elsaad, N., & Ibrahim, T. M. (2023) · Phytotherapy Research · doi:10.1002/ptr.7834 · Cited by 12
Stimulatory Toll-like receptor 2 suppresses restraint stress-induced immune suppression
Hu, D., Denney, J., Liang, M., Javer, A., Yang, X., RuiLiang, Z., & Yin, D. (2013) · Cellular Immunology · doi:10.1016/j.cellimm.2013.05.007 · Cited by 13
Safer topical treatment for inflammation using 5α-tetrahydrocorticosterone in mouse models
Gastaldello, A., Livingstone, D. E. W., Abernethie, A. J., Tsang, N., Walker, B. R., Hadoke, P. W. F., & Andrew, R. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.01.008 · Cited by 13
Metadata
- Authors
- Abraham, S. M., Lawrence, T., Kleiman, A., Warden, P., Medghalchi, M., Tuckermann, J., Saklatvala, J., & Clark, A. R.
- Affiliations
- Imperial College London (GB)
- Leibniz Institute on Aging - Fritz Lipmann Institute (FLI) (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2006-07-31
- Volume
- 203
- Issue
- 8
- Pages
- 1883-1889
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2118371
- OpenAlex
- W2159379486
- Cited by
- 430
- References
- 29
- Citations by year
- 2026: 9 · 2025: 16 · 2024: 12 · 2023: 22 · 2022: 12 · 2021: 19 · 2020: 12 · 2019: 17 · 2018: 13 · 2017: 21 · 2016: 23 · 2015: 24 · 2014: 33 · 2013: 27 · 2012: 28
- FWCI
- 11.27
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- University of Birmingham Research Portal (University of Birmingham) (submittedVersion, other-oa)
- Funders
- Wellcome Trust
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Tyrosine Phosphatases
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Keywords
- dexamethasone, glucocorticoids, MKP-1, MAPK phosphatase, macrophages, c-Jun N-terminal kinase, p38 MAPK, pro-inflammatory gene expression, TNF-α, cyclooxygenase-2, interleukin-1, zymosan-induced inflammation, MAPK dephosphorylation
- MeSH terms
- Animals, Anti-Inflammatory Agents, Bone Marrow, Dexamethasone, Dose-Response Relationship, Drug, Enzyme Induction, Gene Expression Regulation, Glucocorticoids, Inflammation, Macrophages, Phosphoprotein Phosphatases, RNA, Messenger, Signal Transduction, Protein Tyrosine Phosphatases, Immediate-Early Proteins, Cell Cycle Proteins, JNK Mitogen-Activated Protein Kinases, p38 Mitogen-Activated Protein Kinases, Mice, Dual Specificity Phosphatase 1, Protein Phosphatase 1
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review